


Programs
Aiming to treat β-thalassemia and sickle cell disease with gene-edited hematopoietic stem cells




Press Releases
Jun 11, 2022
Jun 11, 2022
Jun 08, 2022
CRISPR Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference



Join Our Team
We're looking for energetic, collaborative and talented people who like challenges, want to make a difference and have a track record of delivering results. View open opportunities


You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.